EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 344 filers reported holding EXELIXIS INC in Q1 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $95 | +14.5% | 4,356 | 0.0% | 0.01% | +25.0% |
| Q2 2023 | $83 | -13.5% | 4,356 | -12.1% | 0.00% | -20.0% |
| Q1 2023 | $96 | +21.5% | 4,956 | 0.0% | 0.01% | +25.0% |
| Q4 2022 | $79 | -99.9% | 4,956 | -6.9% | 0.00% | -20.0% |
| Q3 2022 | $84,000 | -20.8% | 5,321 | +4.8% | 0.01% | 0.0% |
| Q2 2022 | $106,000 | -20.3% | 5,075 | -13.8% | 0.01% | -16.7% |
| Q1 2022 | $133,000 | -22.2% | 5,886 | -37.2% | 0.01% | -14.3% |
| Q4 2021 | $171,000 | -17.0% | 9,369 | -4.1% | 0.01% | -22.2% |
| Q3 2021 | $206,000 | +13.2% | 9,768 | -1.9% | 0.01% | +12.5% |
| Q2 2021 | $182,000 | -19.1% | 9,961 | 0.0% | 0.01% | -27.3% |
| Q1 2021 | $225,000 | +55.2% | 9,961 | +37.7% | 0.01% | +37.5% |
| Q4 2020 | $145,000 | -19.4% | 7,232 | -2.0% | 0.01% | -33.3% |
| Q3 2020 | $180,000 | +9.1% | 7,376 | +6.4% | 0.01% | 0.0% |
| Q2 2020 | $165,000 | – | 6,931 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,001,073 | $199,507,000 | 56.91% |
| Sargent Investment Group, LLC | 1,032,560 | $18,193,000 | 3.40% |
| Bellevue Group AG | 3,930,700 | $69,259,000 | 1.10% |
| CAPITAL MANAGEMENT CORP /VA | 231,880 | $4,086,000 | 1.04% |
| Orbimed Advisors | 3,753,700 | $66,140,000 | 0.94% |
| TEALWOOD ASSET MANAGEMENT INC | 121,848 | $2,147,000 | 0.90% |
| FARALLON CAPITAL MANAGEMENT LLC | 7,500,000 | $132,150,000 | 0.89% |
| Chicago Capital, LLC | 806,113 | $14,204,000 | 0.87% |
| Penn Capital Management Company, LLC | 456,587 | $8,045,000 | 0.84% |
| AJO, LP | 7,636,882 | $134,561,000 | 0.80% |